Linked Life Data

8646418

Source:http://linkedlifedata.com/resource/pubmed/id/8646418

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1996-7-24
pubmed:abstractText
1. Pindolol, cyanopindolol (CYP) and iodocyanopindolol (IodoCYP) have been reported to act either as antagonists, agonists or partial agonists at the beta 3-adrenoceptor in different preparations. A comprehensive investigation has not yet been described with these compounds tested in one tissue from one species. This study was conducted to delineate the pharmacological effects of pindolol, CYP and IodoCYP and to provide data on their affinities at the predominant beta-adrenoceptor in rat ileum. 2. The beta-adrenoceptors present in rat ileum were characterized in the presence of CGP 20712A and ICI 118 551, atropine and corticosterone, with (-)-isoprenaline used as an agonist. The role of the beta 1 and beta 2-adrenoceptors was determined by the omission of either CGP 20712A, ICI 118 551, or both, from the buffers. Conversely, the effectiveness of the beta 1- and beta 2-adrenoceptor blockade was examined by use of the beta 1-adrenoceptor-selective agonist, RO 363 and the beta 2-adrenoceptor-selective agonist, salbutamol. 3. There was no evidence for the presence of functional beta 1-adrenoceptors, and no strong evidence that beta 2-adrenoceptor stimulation contributed to the relaxant effects of (-)-isoprenaline. (-)-Phenylephrine did not produce relaxation of the tissue and 5-hydroxytryptamine produced contraction. 4. The beta 3-adrenoceptor-selective agonist, BRL 37344 and (-)-isoprenaline were potent full agonists (pD2 8.35 +/- 0.04 and 7.76 +/- 0.14 respectively), whereas ICI D7114 was less potent (pseudo pD2 6.92 +/- 0.15). These results indicate that the predominant functional beta-adrenoceptors in rat ileum are beta 3-adrenoceptors. 5. Partial agonist effects were produced by CYP (pD2 5.28 +/- 0.26) and IodoCYP (pD2 7.0 +/- 0.26), but not pindolol. All three compounds antagonized the effects of (-)-isoprenaline with pKb values of 6.68 +/- 0.10, 7.59 +/- 0.07 and 7.59 +/- 0.11 for pindolol, CYP and IodoCYP respectively. Likewise, CYP and IodoCYP antagonized the effects of BRL 37344 with pKb values of 7.20 +/- 0.22 and 7.21 +/- 0.14 respectively. This study provides the first functional data on the effects of IodoCYP, the ligand with the highest known affinity for the beta 3-adrenoceptor, at the characterized rat ileum beta 3-adrenoceptor. 6. In conclusion, whereas pKb values suggest that CYP and IodoCYP have a similar affinity for the beta 3-adrenoceptor in rat ileum, the higher potency of IodoCYP suggests that it promotes a greater coupling efficiency, or that its partial agonist effects are produced through a site other than the beta 3-adrenoceptor. The similar pKb values for CYP and IodoCYP at the beta 3-adrenoceptor contrast with their order of known affinities at the beta 1- and beta 2-adrenoceptors, where IodoCYP is far more potent than CYP. This provides evidence of further differences in the characteristics of the beta 3-adrenoceptors compared to the beta 1- and beta 2-adrenoceptors. Finally, the utility of IodoCYP as a beta 3-adrenoceptor antagonist would appear to be limited because of the greater magnitude of partial agonist effects that it produces.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8646418-1376792, http://linkedlifedata.com/resource/pubmed/commentcorrection/8646418-1679358, http://linkedlifedata.com/resource/pubmed/commentcorrection/8646418-1721063, http://linkedlifedata.com/resource/pubmed/commentcorrection/8646418-1981688, http://linkedlifedata.com/resource/pubmed/commentcorrection/8646418-26747, http://linkedlifedata.com/resource/pubmed/commentcorrection/8646418-2974739, http://linkedlifedata.com/resource/pubmed/commentcorrection/8646418-3014123, http://linkedlifedata.com/resource/pubmed/commentcorrection/8646418-6119625, http://linkedlifedata.com/resource/pubmed/commentcorrection/8646418-6148117, http://linkedlifedata.com/resource/pubmed/commentcorrection/8646418-6288411, http://linkedlifedata.com/resource/pubmed/commentcorrection/8646418-6313663, http://linkedlifedata.com/resource/pubmed/commentcorrection/8646418-7815362, http://linkedlifedata.com/resource/pubmed/commentcorrection/8646418-7903415, http://linkedlifedata.com/resource/pubmed/commentcorrection/8646418-7905770, http://linkedlifedata.com/resource/pubmed/commentcorrection/8646418-7909204, http://linkedlifedata.com/resource/pubmed/commentcorrection/8646418-7915612, http://linkedlifedata.com/resource/pubmed/commentcorrection/8646418-8095419, http://linkedlifedata.com/resource/pubmed/commentcorrection/8646418-8306100
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
117
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
712-6
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Atypical responses of rat ileum to pindolol, cyanopindolol and iodocyanopindolol.
pubmed:affiliation
Central Queensland University, Rockhampton, Australia.
pubmed:publicationType
Journal Article, In Vitro